Developing Alpha-1 Antitrypsin Therapeutics; Public Workshop
The Food and Drug Administration (FDA) is holding a public workshop entitled “ Developing Alpha-1 Antitrypsin Therapeutics. ” The workshop will be cosponsored by the National Heart Lung and Blood Institute of the National Institutes of Health and the Alpha-1 Foundation. The purpose of the workshop is to foster the development of therapeutic products for the treatment of alpha-1 antitrypsin deficiency (AAT deficiency). The workshop will include presentations and a panel discussion by experts from academic institutions, industry, and government agencies.Air date: 9/16/2019 8:00:00 AM (Source: Videocast - All Events)
Source: Videocast - All Events - August 22, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video